Richard Heller

13.7k citations
172 papers · 10.8k · 4 hit papers · h-index 53

Impact in

  • Biotechnology top 0.01%
    • Microbial Inactivation Methods
    • Transgenic Plants and Applications
  • Immunology top 0.5%
    • Toxin Mechanisms and Immunotoxins
    • Immunotherapy and Immune Responses

Papers in

    • Microbial Inactivation Methods 118
    • Transgenic Plants and Applications 44
    • Microfluidic and Bio-sensing Technologies 45
    • 3D Printing in Biomedical Research 10

Richard Heller

168 papers receiving 10.5k citations

Richard Heller's Hit Papers

Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma 2008 · 511 citations
5110+10+21Years since publication2505007501000

Peers

Richard Heller
Comparison fields: 5 of 140
  • Biotechnology 5.1k
  • Immunology 2.6k
  • Oncology 2.8k
  • Physiology 351
  • Biomedical Engineering 2.8k
Replace Julie Gehl with:
Julie Gehl Denmark
Maja Čemažar Slovenia
Gregor Serša Slovenia
Lluis M. Mir France
Abhishek D. Garg Belgium
Rong Xiang China
Ole W. Petersen Denmark
Simone Mocellin Italy
Jane L. Messina United States
Hiroyuki Mizuguchi Japan
Richard Heller relative to Julie Gehl Denmark Julie Gehl's profile →
Citations per field
00.5×1.5×2.1×
Julie Gehl · 1×
Citations per year

Countries citing papers authored by Richard Heller

Since Specialization
Citations

This map shows the geographic impact of Richard Heller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Heller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Heller more than expected).

Fields of papers citing papers by Richard Heller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Heller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Heller. The network helps show where Richard Heller may publish in the future.

Co-authors

The 25 scholars most cited alongside Richard Heller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Richard Heller Line = papers co-authored together Richard Heller links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 172 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
Hit paper breakdown →
20021019
2
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells
Hit paper breakdown →
2003931
3
The Orderly Progression of Melanoma Nodal Metastases
Hit paper breakdown →
1994602
4
Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma
Hit paper breakdown →
2008511
5 1998357
6 1996349
7
Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo.
1999274
8 2014262
9 1996241
10 2000239
11 1998232
12 1994220
13 2002206
14 2006173
15 1999155
16 2009153
17 2010140
18 1997134
19 2000130
20 1991123

About Richard Heller

Richard Heller is a scholar working on Biotechnology, Biomedical Engineering, Molecular Biology, Immunology and Oncology, having authored 172 papers that have together received 10.8k indexed citations. Recurring topics across this work include Microbial Inactivation Methods (118 papers), Microfluidic and Bio-sensing Technologies (45 papers), Transgenic Plants and Applications (44 papers), Toxin Mechanisms and Immunotoxins (26 papers), Viral Infectious Diseases and Gene Expression in Insects (26 papers), Plasma Applications and Diagnostics (11 papers), 3D Printing in Biomedical Research (10 papers) and Cutaneous Melanoma Detection and Management (9 papers). The work is most often cited by research in Biotechnology (5.1k citations), Immunology (2.6k citations), Oncology (2.8k citations), Physiology (351 citations) and Biomedical Engineering (2.8k citations). Richard Heller has collaborated with scholars based in United States, Slovenia and France. Frequent co-authors include Mark J. Jaroszeski, Loreé C. Heller, Richard Gilbert, Domenico Coppola, Richard Jove, Hua Yu, Ronald C. DeConti, M. L. Lucas, Tianhong Wang and Guilian Niu. Their work appears in journals such as Bioelectrochemistry, Gene Therapy, Molecular Therapy, Technology in Cancer Research & Treatment and Human Gene Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact